News Detail
Mumbai, 11 Jan 2025: With revision in extension of the deadline for implementing the revised Schedule M until December 31, 2025, the Indian Drug Manufacturers’ Association (IDMA) has announced plans to intensify its capacity-building initiatives to help pharmaceutical micro......
View Details
Source : Pharmabiz
Deadline
revised Schedule M
Indian Drug Manufacturers’ Association
IDMA
MSMEs
Union ministry of health
Central License Approving Authority
CDSCO
AIPAC
GMP
PQS
PQR
Gujarat FDCA
Related News
- Nepal drug regulator tells pharmacies to stop selling illegal food supplements and cosmetics (11-01-2025)
- Lupin Receives Tentative Approval from U.S. FDA for Ivacaftor Oral Granules (11-01-2025)
- Medtech industry expects regulatory body to reclassify more medical devices (11-01-2025)
- Approvals for medical devices may ease with new classification (11-01-2025)
- Action against quack: 44 types of medicines seized, accused absconding (11-01-2025)
- Customs arrests exporter for smuggling tramadol to Africa (10-01-2025)
- Karnataka HM Dinesh Gundu Rao seeks reforms in drug regulatory framework (10-01-2025)
- Bacteria Use Natural Products to Expose Competitors to Viruses (10-01-2025)
- Centre to reclassify medical devices to bring regulatory uniformity (10-01-2025)
- TechInvention partners with Ethiopia’s Ministry of Health to advance vaccine manufacturing in Africa (10-01-2025)